New PP&P State of Pharmacy Compounding report shows EQUASHIELD ® now accounts for 44% of CSTDs in use for hazardous drug preparation PORT WASHINGTON, N.Y., May 8, 2026 /PRNewswire/ -- In a healthcare ...
PORT WASHINGTON, N.Y., May 13, 2024 /PRNewswire/ -- EQUASHIELD ®, a global leader in the development and distribution of Closed System Transfer Devices (CSTDs) and pharmacy automation solutions, marks ...
PORT WASHINGTON, N.Y., Dec. 3, 2025 /PRNewswire/ -- EQUASHIELD ®, a global leader in Closed System Transfer Devices (CSTD) and pharmacy automation, will highlight its fully integrated hazardous drug ...
Study Finds Equashield is One of Only Two Truly Closed Systems as Defined by Original NIOSH Protocol
University of North Carolina's Eshelman School of Pharmacy studypublished in the Journal of Oncology Pharmacy Practice Equashield (equashield.com), a leading provider of Closed System Transfer Devices ...
Equashield is the first to introduce CSTDs to Romania, helping protect healthcare workers in light of increased demand for chemotherapy drugs PORT WASHINGTON, New ...
PORT WASHINGTON, New York, Nov. 27, 2018 /PRNewswire/ -- Equashield (equashield.com), a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, today announced it will ...
Equashield, a leading provider of Closed System Transfer Devices (CSTDs) for the safe and simple handling of hazardous drugs, today held a groundbreaking for a new manufacturing plant. The company ...
NEW YORK, Sept. 8, 2019 /PRNewswire/ -- Equashield (equashield.com), a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, announced today that, through Japanese ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results